InsidersTradesSigma
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
14
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+50.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Kadre Manuel, Director. Director active across 4 companies, notably MEDNAX, INC.. Cumulatively, 19 filings have been logged. Breakdown: 14 buys · 0 sell. Total volume traded: €3.3m. History available since 12 May 2021. The latest transaction was disclosed on 13 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations19 total
10,500 shares0Common StockSEC:0001628280-25-026104:0
4,755 shares0Common StockSEC:0001628280-24-023363:0
95,109 shares0Common StockSEC:0001628280-23-018544:0
185,000 shares@ US$0.653.5% of flowCommon StockSEC:0001628280-22-032136:0
Ideal exit: 10 Sept 2023 (T+270)
303,307 shares@ US$0.968.7% of flowCommon StockSEC:0001628280-22-030202:0
Ideal exit: 11 Aug 2023 (T+270)
64,487 shares@ US$1.032.0% of flowCommon StockSEC:0001628280-22-029932:0
Ideal exit: 7 Aug 2023 (T+270)
100,000 shares@ US$2.096.8% of flowCommon StockSEC:0001415889-22-002759:0
Ideal exit: 29 Nov 2022 (T+270)
120,000 shares@ US$4.4316.8% of flowCommon StockSEC:0001415889-21-005882:0
Ideal exit: 6 Sept 2022 (T+270)
120,000 shares@ US$4.4336.1% of flowCommon StockSEC:0001415889-21-005882
Ideal exit: 6 Sept 2022 (T+270)
50,000 shares@ US$9.5812.4% of flowCommon StockSEC:0001415889-21-004352
Ideal exit: 5 Jun 2022 (T+270)
50,000 shares@ US$9.5814.5% of flowCommon StockSEC:0001415889-21-004352:0
Ideal exit: 5 Jun 2022 (T+270)
2,105 shares@ US$8.450.5% of flowCommon StockSEC:0001415889-21-003961:0
Ideal exit: 10 May 2022 (T+270)
2,105 shares@ US$8.450.5% of flowCommon StockSEC:0001415889-21-003961
Ideal exit: 10 May 2022 (T+270)
6,661 shares@ US$8.431.7% of flowCommon StockSEC:0001415889-21-003918:0
Ideal exit: 8 May 2022 (T+270)
6,661 shares@ US$8.431.5% of flowCommon StockSEC:0001415889-21-003918
Ideal exit: 8 May 2022 (T+270)
50,000 shares@ US$8.6513.1% of flowCommon StockSEC:0001415889-21-003816:0
Ideal exit: 1 May 2022 (T+270)
50,000 shares@ US$8.6511.2% of flowCommon StockSEC:0001415889-21-003816
Ideal exit: 1 May 2022 (T+270)
4,885 shares0Common StockSEC:0001209191-21-032713
4,885 shares0Common StockSEC:0001209191-21-032713:0
19 of 19 declarations
About Kadre Manuel
Manuel Kadre is a Board Member of Mednax, Inc. and Bright Health Group Inc. He brings his expertise in corporate governance and strategy, contributing to the direction of these companies.
